XOMA Royalty Beheer

Beheer criteriumcontroles 1/4

De CEO XOMA Royalty is Owen Hughes, benoemd in Jan2023, heeft een ambtstermijn van 1.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 2.48M, bestaande uit 5% salaris en 95% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.3% van de aandelen van het bedrijf, ter waarde $ 1.08M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.8 jaar en 5.8 jaar.

Belangrijke informatie

Owen Hughes

Algemeen directeur

US$2.5m

Totale compensatie

Percentage CEO-salaris	5.0%
Dienstverband CEO	1.8yrs
Eigendom CEO	0.3%
Management gemiddelde ambtstermijn	1.8yrs
Gemiddelde ambtstermijn bestuur	5.8yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Owen Hughes's beloning veranderd ten opzichte van XOMA Royalty's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$35m
Jun 30 2024	n/a	n/a	-US$24m
Mar 31 2024	n/a	n/a	-US$42m
Dec 31 2023	US$2m	US$125k	-US$46m

Compensatie versus markt: De totale vergoeding ($USD 2.48M ) Owen } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 988.46K ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Owen te vergelijken met de prestaties van het bedrijf.

CEO

Owen Hughes (49 yo)

1.8yrs

Tenure

US$2,482,735

Compensatie

Mr. Owen P. Hughes, Jr. serves as Chief Executive Officer of XOMA Royalty Corporation (formerly known as XOMA Corporation) from January 2024 and serves as its Director since January 01, 2023 and served as...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Owen Hughes	CEO & Director	1.8yrs	US$2.48m	0.30% $ 1.1m
Thomas Burns	Senior VP of Finance & CFO	9.6yrs	US$2.27m	0.12% $ 451.3k
Brad Sitko	Chief Investment Officer	1.8yrs	US$8.56m	0.060% $ 220.2k

1.8yrs

Gemiddelde duur

49yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 0M26 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.8 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Owen Hughes	CEO & Director	1.8yrs	US$2.48m	0.30% $ 1.1m
Jack Wyszomierski	Independent Chairman	14.3yrs	US$232.53k	0.055% $ 200.4k
Joseph Limber	Independent Director	11.9yrs	US$210.04k	0.053% $ 192.6k
Matthew Perry	Independent Director	7.8yrs	US$197.54k	0.10% $ 365.9k
Barbara Kosacz	Independent Director	5.8yrs	US$196.04k	0% $ 0
Heather Franklin	Independent Director	3.3yrs	US$203.95k	0% $ 0
Natasha Hernday	Independent Director	4.3yrs	US$207.64k	0% $ 0

5.8yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 0M26 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.8 jaar).

XOMA Royalty Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Insufficient new directors

XOMA Corporation, Annual General Meeting, May 15, 2024

Xoma Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Corporation Appoints Owen Hughes as Interim Chief Executive Officer

XOMA Corporation, Annual General Meeting, May 18, 2022

CEO & Director recently sold US$303k worth of stock

Recent updates

New minor risk - Shareholder dilution

Third quarter 2024 earnings released: US$1.47 loss per share (vs US$0.60 loss in 3Q 2023)

Insufficient new directors

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: EPS: US$1.37 (vs US$0.59 loss in 2Q 2023)

First quarter 2024 earnings released: US$0.86 loss per share (vs US$0.98 loss in 1Q 2023)

XOMA Corporation (NasdaqGM:XOMA) completed the acquisition of Kinnate Biopharma Inc. (NasdaqGS:KNTE).

XOMA Corporation, Annual General Meeting, May 15, 2024

Full year 2023 earnings released: US$3.56 loss per share (vs US$1.98 loss in FY 2022)

XOMA Corporation (NasdaqGM:XOMA) entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. (NasdaqGS:KNTE) for approximately $120 million.

XOMA Corporation (NasdaqGM:XOMA) entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. (NasdaqGS:KNTE) for approximately $120 million.

Xoma Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Corporation (NasdaqGM:XOMA) announces an Equity Buyback for $50 million worth of its shares.

New minor risk - Profitability

Third quarter 2023 earnings released: US$0.60 loss per share (vs US$0.48 loss in 3Q 2022)

New major risk - Revenue and earnings growth

First quarter 2023 earnings released: US$0.98 loss per share (vs US$0.32 loss in 1Q 2022)

Full year 2022 earnings released: US$1.50 loss per share (vs US$0.69 profit in FY 2021)

XOMA Corporation Appoints Owen Hughes as Interim Chief Executive Officer

Investor sentiment improved over the past week

Third quarter 2022 earnings released: US$0.48 loss per share (vs US$0.51 loss in 3Q 2021)

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: US$0.53 loss per share (vs US$0.31 loss in 2Q 2021)

Investor sentiment improved over the past week

XOMA Corporation(NasdaqGM:XOMA) dropped from Russell 2000 Dynamic Index

First quarter 2022 earnings released: US$0.32 loss per share (vs US$0.70 loss in 1Q 2021)

Investor sentiment deteriorated over the past week

XOMA Corporation, Annual General Meeting, May 18, 2022

Investor sentiment improved over the past week

Third quarter 2021 earnings released: US$0.51 loss per share (vs US$0.098 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.31 loss per share (vs US$0.33 loss in 2Q 2020)

CEO & Director recently sold US$303k worth of stock

First quarter 2021 earnings released: US$0.70 loss per share (vs US$0.49 loss in 1Q 2020)

Full year 2020 earnings released: EPS US$0.82 (vs US$0.23 loss in FY 2019)

Revenue beats expectations

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd